Alps Advisors Inc. Reduces Stock Position in CVS Health Corporation $CVS

Key Points

• Alps Advisors Inc. trimmed its CVS Health stake by 3.5% in the fourth quarter, leaving it with 315,862 shares valued at about $25.1 million.
• Wall Street sentiment remains constructive, with multiple analysts raising price targets and CVS carrying an average “Moderate Buy” rating and a consensus target of $100.68.
• CVS reported stronger-than-expected quarterly results, posting $2.57 EPS on $100.43 billion in revenue, while also highlighting recent positive business developments such as AI deployment, Aetna’s mental health offering, and expanded GLP-1 coverage.

Alps Advisors Inc. lowered its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 315,862 shares of the pharmacy operator's stock after selling 11,352 shares during the quarter. Alps Advisors Inc.'s holdings in CVS Health were worth $25,067,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of CVS. Sei Investments Co. boosted its holdings in CVS Health by 17.4% during the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock valued at $62,474,000 after acquiring an additional 134,535 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of CVS Health by 1.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock worth $77,353,000 after buying an additional 13,329 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of CVS Health by 1.3% in the 2nd quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock worth $40,358,000 after buying an additional 7,588 shares during the period. HUB Investment Partners LLC lifted its holdings in shares of CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock worth $1,039,000 after buying an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. lifted its holdings in shares of CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock worth $111,017,000 after buying an additional 119,439 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CVS shares. Mizuho upped their target price on CVS Health from $110.00 to $115.00 and gave the stock an "outperform" rating in a report on Monday. Weiss Ratings reiterated a "hold (c)" rating on shares of CVS Health in a report on Friday, May 8th. UBS Group upped their target price on CVS Health from $100.00 to $115.00 and gave the stock a "buy" rating in a report on Monday. JPMorgan Chase & Co. upped their target price on CVS Health from $101.00 to $111.00 and gave the stock an "overweight" rating in a report on Tuesday, May 12th. Finally, Cantor Fitzgerald reiterated an "overweight" rating on shares of CVS Health in a report on Thursday. Twenty-two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $100.68.

Insider Transactions at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares of the company's stock, valued at approximately $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the transaction, the director directly owned 6,213,261 shares in the company, valued at $586,842,501.45. This represents a 24.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 3,441,551 shares of company stock worth $323,703,977 over the last three months. Corporate insiders own 0.85% of the company's stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Health said it is using Fluency’s enterprise AI platform to move autonomous agents from pilot projects into production, a sign it is working to cut administrative costs and improve workflow efficiency across the business. CVS is Using Fluency to Close Enterprise AI Deployment Gap
• Positive Sentiment: Aetna launched “Mental Health on Demand,” which gives members real-time access to care and ongoing support; the company highlighted very fast clinician connection times, underscoring stronger service delivery and potentially better member engagement. Aetna Launches Aetna Mental Health on Demand To Provide Real Time Access to Care and Ongoing Support
• Positive Sentiment: CVS Caremark expanded coverage options for GLP-1 weight-loss medications, a move that may support affordability for members while strengthening the company’s position in a fast-growing and closely watched drug category. CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications With Expanded Coverage Options

CVS Health Trading Up 2.4%

Shares of NYSE CVS opened at $100.38 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market capitalization of $128.08 billion, a P/E ratio of 44.22, a price-to-earnings-growth ratio of 0.96 and a beta of 0.62. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $100.55. The business has a fifty day moving average price of $86.32 and a 200 day moving average price of $80.63.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The firm had revenue of $100.43 billion during the quarter, compared to analysts' expectations of $94.99 billion. During the same period in the prior year, the business posted $2.25 EPS. The firm's quarterly revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts expect that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.6%. CVS Health's dividend payout ratio is currently 117.18%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.